HIGHFDA DRUG

Advanced Pharmaceutical Technology Recalls Testosterone Pellets Due to Contamination Risk

Advanced Pharmaceutical Technology recalled 22,843 cartons of TESTO-100 CIII testosterone pellets on October 3, 2025. The recall follows a risk of microbial contamination that could compromise product sterility. Consumers and healthcare providers should stop using the product immediately and seek guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
October 3, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
October 3, 2025
Hazard Level
HIGH
Brand
Advanced Pharmaceutical Technology
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
3 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Advanced Pharmaceutical Technology
Product type
Testosterone Pellets
Model numbers
Lot #: P-22-3, Exp 06-2027
Sold at
Multiple Retailers
Where affected
GA, NY, TX

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    October 3, 2025

  2. Reported by FDA DRUG

    January 21, 2026

  3. RecallRadar source check

    January 28, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Advanced Pharmaceutical Technology, Inc. or your healthcare provider for guidance. Notification method: Letter

About This Product

TESTO-100 CIII testosterone pellets are used for testosterone replacement therapy in men with low testosterone levels. These pellets offer a convenient method of hormone delivery, usually implanted under the skin.

Why This Is Dangerous

The potential microbial contamination in these pellets poses a risk of infections or other health complications if used. This contamination can occur during the manufacturing process, compromising the product's safety.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers may face health risks if they use the contaminated product. Stopping use and seeking alternative treatments is critical for safety.

Practical Guidance

How to identify if yours is affected

  1. Check the product packaging for the lot number P-22-3.
  2. Verify the expiration date, which should be June 2027.
  3. If you have the product, confirm it matches the recalled lot and expiration.

Where to find product info

The lot number and expiration date can be found on the packaging of the product.

What timeline to expect

Expect a timeline of 4-6 weeks for refund processing after returning the product.

If the manufacturer is unresponsive

  • Document your attempts to contact the manufacturer.
  • Reach out to your healthcare provider for additional support.
  • Consider filing a complaint with the FDA if you receive no response.

How to prevent similar issues

  • Always check for recalls before using medications or supplements.
  • Look for FDA approval and certification when purchasing health products.
  • Consult with healthcare providers about any concerns regarding medications.

Documentation advice

Keep records of your correspondence with the manufacturer, including any confirmation letters or emails.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall involves TESTO-100 CIII testosterone pellets, 100 mg, sold in cartons of 10 sterile pellets. The affected lot number is P-22-3, with an expiration date of June 2027. The product was distributed in Georgia, New York, Texas, Puerto Rico, the United Kingdom, Malta, and Greece.

Key Facts

  • Recall date: October 3, 2025
  • Quantity recalled: 22,843 pellets
  • Affected lot number: P-22-3
  • Expiration date: June 2027
  • Distribution states: GA, NY, TX, Puerto Rico, UK, Malta, Greece

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
Lot #: P-22-3
Exp 06-2027
Affected States
GA, NY, TX
Report Date
January 21, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more